Email this article 
Fertility Preservation with Gonadotoxic Cancer Therapy: Review
Abstract
Abstract
Malignant haematological conditions have recognized an expanded rate and require aggressive medicines. Designated chemotherapy, accompanied or not by radiotherapy, raises the possibility overcoming the disease, yet cancer protocols frequently associate long term gonadal consequences, for example, reduced or damaged ovarian reserve. The negative consequence is directly proportional to the types, doses, time of administration of chemotherapy, and irradiation. Moreover, follicle damage relies upon characteristics of the disease and patient, like age, concomitant diseases, previous gynaecological conditions, and ovarian reserve. Patients ought to be enough educated while continuing to gonadotoxic treatments; consequently, fertility conservation ought to be in the long run viewed as a first-aim procedure. This procedure is most valuable when performed before the beginning of cancer treatment, with the recommendation for embryos’ or oocytes' cryopreservation. If not possible or satisfactory, a few choices can be accessible during or after the cancer treatment. Albeit not supported by medical practice, promising outcomes after in vitro studies increment the possibilities of future patients to protect their fertility. This review means to accentuate the mechanism of action and effect of chemotherapy, particularly the one demonstrated to be gonadotoxic, upon ovarian reserve and future fertility. Reduced fertility or infertility, as long term outcomes of chemotherapy and, especially, following bone marrow transplantation, is frequently associated with a negative effect of recovery, social and personal life, as well as exceptionally diminished personal satisfaction.
Keywords
Full Text:
PDFReferences
Majhail, Navneet S., et al. "Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation." Biology of Blood and Marrow Transplantation 21.11 (2015): 1863-1869.
Méndez-Ferrer, Simón, et al. "Bone marrow niches in haematological malignancies." Nature Reviews Cancer 20.5 (2020): 285-298.
Mauri, Davide, et al. "Chemotherapy associated ovarian failure." Frontiers in Endocrinology 11 (2020): 572388.
Inamoto, Yoshihiro, and Stephanie J. Lee. "Late effects of blood and marrow transplantation." Haematologica 102.4 (2017): 614.
Ben-Aharon, Irit, and Ruth Shalgi. "What lies behind chemotherapy-induced ovarian toxicity?" Reproduction 144.2 (2012): 153-163.
Kort, Jonathan D., et al. "Fertility issues in cancer survivorship." CA: a cancer journal for clinicians 64.2 (2014): 118-134.
Humphreys, Meredith, Erica Johnstone, and Joseph M. Letourneau. "Current Approaches to Fertility Preservation." Clinical Obstetrics and Gynecology 63.4 (2020): 735-751.
Wallace, W. Hamish B., Richard A. Anderson, and D. Stewart Irvine. "Fertility preservation for young patients with cancer: who is at risk and what can be offered?" The lancet oncology6.4 (2005): 209-218.
Jadoul, Pascale, and S. Samuel Kim. "Fertility considerations in young women with hematological malignancies." Journal of assisted reproduction and genetics 29.6 (2012): 479-487.
Sonigo, Charlotte, et al. "The impact of chemotherapy on the ovaries: molecular aspects and the prevention of ovarian damage." International Journal of Molecular Sciences 20.21 (2019): 5342.
Silvestris, Erica, et al. "Novel aspects on gonadotoxicity and fertility preservation in lymphoproliferative neoplasms." Critical Reviews in Oncology/Hematology 151 (2020): 102981.
Sun, Bei, and John Yeh. "Onco-fertility and personalized testing for potential for loss of ovarian reserve in patients undergoing chemotherapy: Proposed next steps for development of genetic testing to predict changes in ovarian reserve." Fertility Research and Practice 7.1 (2021): 1-16.
Stroud, Jaymeson S., et al. "Effects of cancer treatment on ovarian function." Fertility and sterility 92.2 (2009): 417-427.
Szymanska, Katarzyna J., Xiujuan Tan, and Kutluk Oktay. "Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging." Molecular Human Reproduction 26.8 (2020): 553-566.
Mehedintu, Claudia, et al. "A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment." Medicina 57.12 (2021): 1340.
Williams, Carmen J., and Gregory F. Erickson. "Morphology and Physiology of the Ovary." (2015).
Erickson, G. F. "Follicle Growth and Development, Global Library Women’s Med." Follicle Growth and Development. Global Library Women’s Med (2008).
Pelosi, E., A. Forabosco, and D. Schlessinger. "Genetics of the ovarian reserve. Front Genet 6 (308)." (2015).
Holesh, Julie E., Autumn N. Bass, and Megan Lord. "Physiology, ovulation." (2017).
Richards, JoAnne S., and Stephanie A. Pangas. "The ovary: basic biology and clinical implications." The Journal of clinical investigation 120.4 (2010): 963-972.
Ouni, E., et al. "Spatiotemporal changes in mechanical matrisome components of the human ovary from prepuberty to menopause." Human Reproduction 35.6 (2020): 1391-1410.
Gougeon, Alain. "Human ovarian follicular development: from activation of resting follicles to preovulatory maturation." Annales d'endocrinologie. Vol. 71. No. 3. Elsevier Masson, 2010.
De Felici, Massimo, and Francesca Gioia Klinger. "Pi3k/pten/akt signaling pathways in germ cell development and their involvement in germ cell tumors and ovarian dysfunctions." International Journal of Molecular Sciences22.18 (2021): 9838.
Zeleznik, Anthony J. "The physiology of follicle selection." Reproductive Biology and Endocrinology 2.1 (2004): 1-7.
Gordon, Catherine E., and Elena Yanushpolsky. "Anti-Müllerian Hormone: Current Understanding and Clinical Use." Current Obstetrics and Gynecology Reports (2021): 1-10.
Yang, Dong Zi, et al. "Progress in understanding human ovarian folliculogenesis and its implications in assisted reproduction." Journal of assisted reproduction and genetics30.2 (2013): 213-219.
Richards, JoAnne S., et al. "Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization." Recent progress in hormone research 57.1 (2002): 195-220.
Luan, Yi, et al. "Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide." Journal of Endocrinology240.2 (2019): 243-256.
Terren, Carmen, Michelle Nisolle, and Carine Munaut. "Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture." Journal of ovarian research 14.1 (2021): 1-15.
Vallet, Nicolas, et al. "Can Some Anticancer Treatments Preserve the Ovarian Reserve?" The Oncologist 26.6 (2021): 492-503.
Nho, Richard Seonghun, and Polla Hergert. "FoxO3a and disease progression." World journal of biological chemistry 5.3 (2014): 346.
Maidarti, Mila, Richard A. Anderson, and Evelyn E. Telfer. "Crosstalk between PTEN/PI3K/Akt signalling and DNA damage in the oocyte: implications for primordial follicle activation, oocyte quality and ageing." Cells 9.1 (2020): 200.
Vo, Kim Cat Tuyen, and Kazuhiro Kawamura. "Female oncofertility: Current understandings, therapeutic approaches, controversies, and future perspectives." Journal of Clinical Medicine 10.23 (2021): 5690.
Georgescu, Maria-Magdalena. "PTEN tumor suppressor network in PI3K-Akt pathway control." Genes & cancer 1.12 (2010): 1170-1177.
Kano, Motohiro, et al. "AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy." Proceedings of the National Academy of Sciences 114.9 (2017): E1688-E1697.
Nguyen, Q. N., et al. "Cisplatin-and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes." Molecular human reproduction 25.8 (2019): 433-444.
Roness, Hadassa, et al. "Ovarian follicle burnout: a universal phenomenon?" Cell Cycle 12.20 (2013): 3245-3246.
Medica, Panminerva. "Female infertility and assisted reproductive technology." Panminerva medica 61.1 (2019): 52-7.
Bedoschi, Giuliano, Paula Andrea Navarro, and Kutluk Oktay. "Chemotherapy-induced damage to ovary: mechanisms and clinical impact." Future oncology 12.19 (2016): 2333-2344.
Spears, Norah, et al. "Ovarian damage from chemotherapy and current approaches to its protection." Human reproduction update 25.6 (2019): 673-693.
Campia, Umberto. "Vascular effects of cancer treatments." Vascular Medicine 25.3 (2020): 226-234.
Oktay, Kutluk, and Murat Sönmezer. "Chemotherapy and amenorrhea: risks and treatment options." Current Opinion in Obstetrics and Gynecology 20.4 (2008): 408-415.
Kim, Seongmin, et al. "Molecular mechanism and prevention strategy of chemotherapy-and radiotherapy-induced ovarian damage." International Journal of Molecular Sciences 22.14 (2021): 7484.
Cho, Hyun-Woong, et al. "Advances in the treatment and prevention of chemotherapy-induced ovarian toxicity." International Journal of Molecular Sciences 21.20 (2020): 7792.
Cho, H.-W.; Lee, S.; Min, K.-J.; Hong, J.H.; Song, J.Y.; Lee, J.K.; Lee, N.W.; Kim, T. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity. Int. J. Mol. Sci. 2020, 21, 7792.
Gavish, Zohar, et al. "Follicle activation and ‘burn-out’contribute to post-transplantation follicle loss in ovarian tissue grafts: the effect of graft thickness." Human reproduction 29.5 (2014): 989-996.
Meirow, Dror, and David Nugent. "The effects of radiotherapy and chemotherapy on female reproduction." Human reproduction update 7.6 (2001): 535-543.
Ogilvy-Stuart, Amanda L., and Stephen M. Shalet. "Effect of radiation on the human reproductive system." Environmental health perspectives 101.suppl 2 (1993): 109-116.
Paix, Adrien, et al. "Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review." Critical reviews in oncology/hematology 123 (2018): 138-148.
Rozen, G., et al. "Clinical summary guide: reproduction in women with previous abdominopelvic radiotherapy or total body irradiation." Human Reproduction Open 2020.4 (2020): hoaa045.
Wong, Jeffrey YC, et al. "Total body irradiation: guidelines from the international lymphoma radiation oncology group (ILROG)." International Journal of Radiation Oncology* Biology* Physics 101.3 (2018): 521-529.
Teh, Wan Tinn, et al. "The impact of uterine radiation on subsequent fertility and pregnancy outcomes." BioMed research international 2014 (2014).
Forgeard, Nathalie, et al. "Sexuality-and fertility-related issues in women after allogeneic hematopoietic stem cell transplantation." Transplantation and Cellular Therapy 27.5 (2021): 432-e1.
HUANG, KO-EN. "Assessment of hypothalamic-pituitary function in women after external head irradiation." The Journal of Clinical Endocrinology & Metabolism 49.4 (1979): 623-627.
Farhadfar, Nosha, et al. "Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes." Bone marrow transplantation 53.8 (2018): 977-982.
Detti, Laura. "Options for preserving fertility in women undergoing gonadotoxic treatment." Cleveland Clinic Journal of Medicine 88.11 (2021): 607-612.
Jing, Yuan-Xue, et al. "Fertility preservation in cancer patients." Reproductive and Developmental Medicine 5.01 (2021): 44-54.
Bratila, Elvira. "The 13th National Congress of Urogynecology." (2016).
Hussein, Reda S., Zaraq Khan, and Yulian Zhao. "Fertility preservation in women: indications and options for therapy." Mayo Clinic Proceedings. Vol. 95. No. 4. Elsevier, 2020.
Kasum, Miro, et al. "Fertility preservation with ovarian stimulation protocols prior to cancer treatment." Gynecological Endocrinology 30.3 (2014): 182-186.
Parton, Chloe, Jane M. Ussher, and Janette Perz. "Hope, burden or risk: a discourse analytic study of the construction and experience of fertility preservation in the context of cancer." Psychology & health 34.4 (2019): 456-477.
Mehedintu, Claudia, et al. "A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment." Medicina 57.12 (2021): 1340.
Harada, Miyuki, and Yutaka Osuga. "Fertility preservation for female cancer patients." International Journal of Clinical Oncology 24.1 (2019): 28-33.
Mehedintu, Claudia, et al. "A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment." Medicina 57.12 (2021): 1340.
de Carvalho, Bruno Ramalho, et al. "Ovarian reserve evaluation: state of the art." Journal of Assisted Reproduction and Genetics 25.7 (2008): 311-322.
William, E. R., and J. Wendy. "Biomarkers of ovarian reserve." Biomark Insights 3 (2008): 259-268.
Pinelli, Sara, and Stefano Basile. "Fertility preservation: current and future perspectives for oncologic patients at risk for iatrogenic premature ovarian insufficiency." BioMed research international 2018 (2018).
Lee, Jae Hoon, and Young Sik Choi. "The role of gonadotropin-releasing hormone agonists in female fertility preservation." Clinical and Experimental Reproductive Medicine 48.1 (2021): 11.
Weterings, Maria AJ, et al. "Interventions for fertility preservation in women with cancer undergoing chemotherapy." The Cochrane Database of Systematic Reviews 2017.12 (2017).
Dolmans, Marie‐Madeleine, and Diego D. Manavella. "Recent advances in fertility preservation." Journal of Obstetrics and Gynaecology Research 45.2 (2019): 266-279.
Salama, Mahmoud, and Peter Mallmann. "Emergency fertility preservation for female patients with cancer: clinical perspectives." Anticancer Research 35.6 (2015): 3117-3127.
Liebenthron, Jana, and Markus Montag. "Cryopreservation and Thawing of Human Ovarian Cortex Tissue Slices." Cryopreservation and Freeze-Drying Protocols. Humana, New York, NY, 2021. 485-499.
Alvarez, R. M., and P. Ramanathan. "Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response." Human Reproduction 33.11 (2018): 2051-2059.
Terren, Carmen, and Carine Munaut. "Molecular basis associated with the control of primordial follicle activation during transplantation of cryopreserved ovarian tissue." Reproductive Sciences 28.5 (2021): 1257-1266.
Shapira, Moran, et al. "Fertility preservation in young females with hematological malignancies." Acta Haematologica 132.3-4 (2014): 400-413.
Salama, Mahmoud, et al. "Advances in fertility preservation of female patients with hematological malignancies." Expert Review of Hematology 10.11 (2017): 951-960.
Dolmans, Marie-Madeleine, Jacques Donnez, and Luciana Cacciottola. "Fertility preservation: the challenge of freezing and transplanting ovarian tissue." Trends in molecular medicine 27.8 (2021): 777-791.
Chen, Jing, et al. "Optimization of Follicle Isolation for Bioengineering of Human Artificial Ovary." Biopreservation and Biobanking (2021).
Lambertini, Matteo, et al. "Cancer and fertility preservation: international recommendations from an expert meeting." BMC medicine 14.1 (2016): 1-16.
Hoekman, Ellen J., et al. "Ovarian survival after pelvic radiation: transposition until the age of 35 years." Archives of Gynecology and Obstetrics 298.5 (2018): 1001-1007.
Chuai, Yunhai, Xiaobin Xu, and Aiming Wang. "Preservation of fertility in females treated for cancer." International journal of biological sciences 8.7 (2012): 1005.
Donnez, Jacques, and Marie-Madeleine Dolmans. "Fertility preservation in women." New England Journal of Medicine377.17 (2017): 1657-1665.
Marder, Wendy, Évelyne Vinet, and Emily C. Somers. "Rheumatic autoimmune diseases in women and midlife health." Women's midlife health 1.1 (2015): 1-8.
Del Pozo Lérida, Sofía, et al. "Preservation of fertility in patients with cancer." Oncology reports 41.5 (2019): 2607-2614.
85- Martinez, Francisca, et al. "Update on fertility preservation from the Barcelona International Society for Fertility Preservation–ESHRE–ASRM 2015 expert meeting: indications, results and future perspectives." Fertility and sterility 108.3 (2017): 407-415.
Javed, Murid, and Essam Michael. "Fertility Preservation Options for Cancer Patients." Advances in Reproductive Sciences 3.04 (2015): 67.
Shalet, Stephen M., et al. "Vulnerability of the human Leydig cell to radiation damage is dependent upon age." Journal of Endocrinology 120.1 (1989): 161-165.
Rodriguez-Wallberg, Kenny A., and Kutluk Oktay. "Fertility preservation during cancer treatment: clinical guidelines." Cancer management and research 6 (2014): 105.
Cakmak, Hakan, and Mitchell P. Rosen. "Ovarian stimulation in cancer patients." Fertility and sterility 99.6 (2013): 1476-1484.
Desai, Nina, et al. "Vitrification of mouse embryo-derived ICM cells: a tool for preserving embryonic stem cell potential?" Journal of assisted reproduction and genetics 28.2 (2011): 93-99.
Rezazadeh Valojerdi, Mojtaba, et al. "Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos." Journal of Assisted Reproduction and Genetics26.6 (2009): 347-354.
Vajta, Gábor, and Masashige Kuwayama. "Improving cryopreservation systems." Theriogenology 65.1 (2006): 236-244.
Del Pozo Lérida, Sofía, et al. "Preservation of fertility in patients with cancer." Oncology reports 41.5 (2019): 2607-2614.
Mahajan, Nalini. "Fertility preservation in female cancer patients: an overview." Journal of human reproductive sciences 8.1 (2015): 3.
Donnez, Jacques, and Marie-Madeleine Dolmans. "Fertility preservation in women." New England Journal of Medicine377.17 (2017): 1657-1665.
Lim, Jin-Ho, and Ri-Cheng Chian. "In vitro maturation of human immature oocytes." Journal of Reproductive and Stem Cell Biotechnology 1.2 (2010): 169-180.
Meirow, Dror, et al. "Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy." New England Journal of Medicine 353.3 (2005): 318-321.
Donnez, Jacques, and Marie-Madeleine Dolmans. "Fertility preservation in women." New England Journal of Medicine377.17 (2017): 1657-1665.
Von Wolff, Michael, Nicole Sänger, and Jana Liebenthron. "Is Ovarian Tissue Cryopreservation and Transplantation Still Experimental? It Is a Matter of Female Age and Type of Cancer." Journal of clinical oncology 36.33 (2018): 3340-3341.
Ernst, Emil Hagen, et al. "Legal termination of a pregnancy resulting from transplanted cryopreserved ovarian tissue due to cancer recurrence." Journal of assisted reproduction and genetics 30.7 (2013): 975-978.
Tulandi, Togas. "Ovarian transposition before pelvic radiation." Waltham, MA (2020).
Oktay, Kutluk, and Murat Sönmezer. "Chemotherapy and amenorrhea: risks and treatment options." Current Opinion in Obstetrics and Gynecology 20.4 (2008): 408-415.
Lambertini, Matteo, Ann H. Partridge, and Lucia Del Mastro. "Reply to V. Turan et al." Journal of clinical oncology: official journal of the American Society of Clinical Oncology 37.1 (2018): 86-88.
104- Del Mastro, Lucia, et al. "Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials." Cancer treatment reviews 40.5 (2014): 675-683.
Demeestere, Isabelle, et al. "No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial." Journal of Clinical Oncology 34.22 (2016): 2568-2574.
Griesinger, Georg, and Bart CJM Fauser. "Drug-free in-vitro activation of ovarian cortex; can it really activate the ‘ovarian gold reserve’?" Reproductive Biomedicine Online 40.2 (2020): 187-189.
Novella-Maestre, Edurne, et al. "Short-term PTEN inhibition improves in vitro activation of primordial follicles, preserves follicular viability, and restores AMH levels in cryopreserved ovarian tissue from cancer patients." PLoS One 10.5 (2015): e0127786.
Callahan, Michael J., et al. "Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction." Journal of Clinical Oncology25.25 (2007): 3985-3990.
Ben-Aharon, Irit, et al. "Optimizing the process of fertility preservation in pediatric female cancer patients–a multidisciplinary program." BMC cancer 16.1 (2016): 1-9.
Luyckx, Valérie, et al. "A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold." Fertility and sterility 101.4 (2014): 1149-1156.
Amorim, Christiani A., and Ariella Shikanov. "The artificial ovary: current status and future perspectives." Future oncology 12.19 (2016): 2323-2332.
Ahn, Richard W., et al. "A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast CancerEnhanced Antitumor Efficacy of As2O3-Loaded Nanobins." Clinical cancer research 16.14 (2010): 3607-3617.
Ahn, Richard W., et al. "Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo." PloS one 8.3 (2013): e58491.
Harada, Miyuki, and Yutaka Osuga. "Fertility preservation for female cancer patients." International Journal of Clinical Oncology 24.1 (2019): 28-33.
Del Pozo Lérida, Sofía, et al. "Preservation of fertility in patients with cancer." Oncology reports 41.5 (2019): 2607-2614.
Grover, Natalie S., et al. "Young men with cancer experience low referral rates for fertility counseling and sperm banking." Journal of oncology practice 12.5 (2016): 465-471.
Pacey, Allan A., and Christine Eiser. "Banking sperm is only the first of many decisions for men: What healthcare professionals and men need to know." Human fertility 14.4 (2011): 208-217.
Katz, Darren J., et al. "Fertility preservation strategies for male patients with cancer." Nature Reviews Urology 10.8 (2013): 463-472.
Chan, Peter TK, et al. "Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy." Cancer 92.6 (2001): 1632-1637.
Sasaki, Sachiko, et al. "Successful pregnancy outcome using sperm from severely diseased men with testicular cancer and collagen disease: Three case reports." Reproductive medicine and biology 3.2 (2004): 69-75.
Goossens, Ellen, Dorien Van Saen, and Herman Tournaye. "Spermatogonial stem cell preservation and transplantation: from research to clinic." Human reproduction 28.4 (2013).
Braye, Aude, Herman Tournaye, and Ellen Goossens. "Setting up a cryopreservation programme for immature testicular tissue: lessons learned after more than 15 years of experience." Clinical Medicine Insights: Reproductive Health13 (2019): 1179558119886342.
Stukenborg, Jan-Bernd, et al. "New horizons for in vitro spermatogenesis? An update on novel three-dimensional culture systems as tools for meiotic and post-meiotic differentiation of testicular germ cells." Molecular human reproduction 15.9 (2009): 521-529.
Mehedintu, Claudia, et al. "A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment." Medicina 57.12 (2021): 1340.
Mahajan, Nalini. "Fertility preservation in female cancer patients: an overview." Journal of human reproductive sciences 8.1 (2015): 3.
Blumenfeld, Zeev. "Fertility preservation using GnRH agonists: rationale, possible mechanisms, and explanation of controversy." Clinical Medicine Insights: Reproductive Health13 (2019): 1179558119870163.
Mehedintu, Claudia, et al. "A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment." Medicina 57.12 (2021): 1340.
Dumitrascu, Mihai Cristian, et al. "Carcinogenic effects of bisphenol A in breast and ovarian cancers." Oncology Letters20.6 (2020): 1-1.
Blumenfeld, Z. "Critical Care for Young Women—Before Chemotherapy: Preserving Fertility Using GnRH Agonists." Crit. Care Obs. Gyne 2.3 (2016).
Lambertini, Matteo, et al. "Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: from biological evidence to clinical application." Cancer treatment reviews 72 (2019): 65-77.
Blumenfeld, Zeev. "Fertility preservation and GnRHa for chemotherapy: Debate." Cancer Management and Research6 (2014): 313.
132- Sonigo, Charlotte, et al. "AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide‐treated mice." The FASEB Journal 33.1 (2019): 1278-1287.
133- Roness, H., et al. "Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects." Journal of assisted reproduction and genetics 36.9 (2019): 1793-1803.
Lee, Hye Nam, and Eun Mi Chang. "Primordial follicle activation as new treatment for primary ovarian insufficiency." Clinical and experimental reproductive medicine 46.2 (2019): 43.
Lee, Hye Nam, and Eun Mi Chang. "Primordial follicle activation as new treatment for primary ovarian insufficiency." Clinical and experimental reproductive medicine 46.2 (2019): 43.
Roness, Hadassa, Oren Kashi, and Dror Meirow. "Prevention of chemotherapy-induced ovarian damage." Fertility and sterility 105.1 (2016): 20-29.
Oktem, Ozgur, and Kutluk Oktay. "Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function." Cancer: Interdisciplinary International Journal of the American Cancer Society 110.10 (2007): 2222-2229.
Goeckenjan, Maren, et al. "Motherhood after cancer: fertility and utilisation of fertility-preservation methods." Archives of Gynecology and Obstetrics 301.6 (2020): 1579-1588.
Henry, N. Lynn, et al. "Prediction of postchemotherapy ovarian function using markers of ovarian reserve." The oncologist19.1 (2014): 68-74.
Victoria, Mathilde, et al. "Anti Müllerian hormone: more than a biomarker of female reproductive function." Journal of gynecology obstetrics and human reproduction 48.1 (2019): 19-24.
Moravek, Molly B., et al. "Long-term outcomes in cancer patients who did or did not pursue fertility preservation." Fertility and sterility 109.2 (2018): 349-355.
Muñoz, Elkin, et al. "Oocyte donation outcome after oncological treatment in cancer survivors." Fertility and sterility103.1 (2015): 205-213.
Marklund, Anna, et al. "Pregnancy achieved using donor eggs in cancer survivors with treatment-induced ovarian failure: obstetric and perinatal outcome." Journal of Women's Health27.7 (2018): 939-945.
Gorman, Jessica R., et al. "A multidimensional scale to measure the reproductive concerns of young adult female cancer survivors." Journal of Cancer Survivorship 8.2 (2014): 218-228.
Boivin, Jacky, Janet Takefman, and Andrea Braverman. "The fertility quality of life (FertiQoL) tool: development and general psychometric properties." Human Reproduction 26.8 (2011): 2084-2091.
DOI: http://dx.doi.org/10.52155/ijpsat.v33.1.4425
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Maged Naser
This work is licensed under a Creative Commons Attribution 4.0 International License.